Ken Griffin Tandem Diabetes Care Inc Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$35.21 - $47.3 $1.39 Million - $1.86 Million	-39,400 Reduced 65.67%	20,600 $873,000
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $1.36 Million - $2.39 Million	44,800 Added 294.74%	60,000 $2.42 Million
Q1 2024 May 15, 2024	SELL	$22.09 - $35.41 $101,614 - $162,885	-4,600 Reduced 23.23%	15,200 $538,000
Q4 2023 Feb 14, 2024	SELL	$14.28 - $31.03 $371,280 - $806,780	-26,000 Reduced 56.77%	19,800 $585,000
Q3 2023 Nov 14, 2023	BUY	$19.33 - $36.22 $133,377 - $249,918	6,900 Added 17.74%	45,800 $951,000
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $594,828 - $1.04 Million	-24,600 Reduced 38.74%	38,900 $954,000
Q1 2023 May 15, 2023	SELL	$35.86 - $46.5 $616,792 - $799,800	-17,200 Reduced 21.31%	63,500 $2.58 Million
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $1.59 Million - $2.52 Million	-44,800 Reduced 35.7%	80,700 $3.63 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $1.48 Million - $2.34 Million	33,900 Added 37.01%	125,500 $6.01 Million

361

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.16B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.